Evaluation of alkaloid contents, acute toxicity and antitussive activity of the bracts of two varieties of Bougainvillea glabra Choisy

  • Carmita Gladys Jaramillo-Jaramillo Universidad Técnica de Machala, Facultad de Ciencias Químicas y de la Salud. Machala, Ecuador
  • Katherine Amarilis Zambrano- Gonzaga Universidad Técnica de Machala, Facultad de Ciencias Químicas y de la Salud. Machala, Ecuador
  • Juan Carlos Armijos-Aguilar Universidad Técnica de Machala, Facultad de Ciencias Químicas y de la Salud. Machala, Ecuador
  • Sylvana Alexandra Cuenca-Buele Universidad Técnica de Machala, Facultad de Ciencias Químicas y de la Salud. Machala, Ecuador - Sociedad de Lucha contra el Cáncer del Ecuador (SOLCA), núcleo Machala. Machala, Ecuador
  • Manuel Tocto-León Universidad Técnica de Machala, Facultad de Ciencias Químicas y de la Salud. Machala, Ecuador
  • Luisa Rojas de Astudillo Universidad de Oriente, Departamento de Química. Venezuela
Keywords: Bougainvillea glabra, bracts, acute toxicity, CD1 mice, alkaloids

Abstract

The Bougainvillea glabra Choisy plant, used for the treatment of various diseases, occurs in varieties due to the color of its bracts, which show different chemical compositions, which gives the possibility of presenting various therapeutic activities and potentially different toxic effects. Hence the importance of evaluating both the pharmacological activity and the toxicity of the bracts with different colors of B. glabra. In this investigation, the antitussive activity and acute toxicity of orange and purple bracts of B. glabra, respectively, were evaluated. For preclinical acute toxicity tests, a dose of 2,000 mg·kg-1 of the extract of the purple and orange bracts of B. glabra, respectively, was applied to CD1 mice, which was non-toxic when ingested orally. For the antitussive activity, CD1 mice were used and were divided into 6 groups, a control group and five groups that were administered the doses of 250 mg·kg-1 (T1 and T2) and 500 mg.kg-1 (T3 y T4) of the dry extract of the purple bracts, oranges, and codeine (30 mg·kg-1) (T5) as positive control, respectively. Antitussive activity occurred in all treatments, but the 250 mg·kg-1 treatment of the orange bracts (T2) provided significantly (P<0.05) the highest antitussive activity, compared to the 500 mg·kg-1 treatment of the same color (T4) and the other treatments (T1, T3 and T5). The orange bracts had higher concentrations (0.24 ± 0.02) mg·g-1 of alkaloids than the purple ones (0.16 ± 0.02) mg·g-1. Apparently, the orange bracts of B. glabra decrease the effectiveness of the antitussive activity when the concentration of the extract increases due to the high content of alkaloids. This study provides evidence that the purple and orange bracts of B. glabra have antitussive activity, at the doses used and without acute toxicity effects.

Downloads

Download data is not yet available.

References

Alqudaihi KS, Aslam N, Khan IU, Almuhaideb AM, Alsunaidi SJ, Ibrahim NMAR, Alhaidari F, Shaik F, Alsenbel Y.M, Alalharith DM, Alharthi HM, Alghamdi WM, Alshahrani MS. Cough sound detection and diagnosis using artificial intelligence techniques: Challenges and opportunities. IEEE Access. 2021; 9:102327–102344. doi: https://doi.org/kbd8

Koskela H, Lätti A, Pekkanen J. The impacts of cough: a cross–sectional study in a Finnish adult employee population. ERJ Open Res. 2018; 4:00113–2018. doi: https://doi.org/ggdg64

Lam SH, Homme J, Avarello J, Heins A, Pauze D, Mace S, Dietrich A, Stoner M. Use of antitussive medications in acute cough in young children. J. Ame. Coll. Emerg. Physicians Open. 2021; 2(3):e12467. doi: https://doi.org/kbfb

Chamberlain SA, Garrod R, Douiri A, Masefield S, Powell P, Bücher C, Pandyan A, Morice AH, Birring SS. 2015; 193(3):401–408. doi: https://doi.org/kbfd

Moghaddam GM, Kianmehr M, Khazdair MR. The possible therapeutic effects of some medicinal plants for chronic cough in children. Evid. Based Complement Alternat. Med. 2020; 2020:2149328. doi: https://doi.org/gpjktx

Organización Mundial de la Salud (OMS). Estrategia de la OMS sobre medicina tradicional 2014–2023. [Internet]. Hong Kong: OMS; 2013 [Consultado 3 Sep 2022]. Disponible en: https://bit.ly/3Mm52nT.

Haile AA, Tsegay BA, Seid A, Adnew W, Moges A. A review on medicinal plants used in the management of respiratory problems in Ethiopia over a twenty–year period (2000–2021). Evid. Based Complement. Alternat. Med. 2022; 2022:2935015. doi: https://doi.org/kbff.

Waizel–Bucay J, Waizel–Haiat S. Antitussive plants used in Mexican traditional medicine. Phcog. Rev. 2009; 3(5): 29–43.

Abarca–Vargas R, Petricevich VL. Bougainvillea Genus: A Review on Phytochemistry, Pharmacology, and Toxicology. Evid. Based Complement. Alternat. Med. 2018; 2018:9070927. doi: https://doi.org/gdwm3h.

Saleem H, Usman A, Mahomoodally MF, Ahemad N. Bougainvillea glabra (Choisy): A comprehensive review on botany, traditional uses, phytochemistry, pharmacology and toxicity. J. Ethnopharmacol. 2021; 266:113356. doi: https://doi.org/kbfg.

Boukandou–Mounanga M, Mewono L, Aboughe–Angone S. Toxicity studies of medicinal plants used in sub–Saharan Africa. J. Ethnopharmacol. 2015; 174: 618–627. doi: https://doi.org/f7zmnw.

Anywar G, Kakudidi E, Byamukama R, Mukonzo J, Schubert A, Oryem–Origa H, Jassoy C. A Review of the toxicity and phytochemistry of medicinal plant species used by herbalists in treating people living with HIV/AIDS in Uganda. Front Pharmacol. 2021; 12:615147. doi: https://doi.org/kbfh.

Krishna R, Sundararajan R. Toxicity studies of Bougainvillea glabra and Mucuna pruriens. Intern. J. Pharm. Sci. Res. 2020; 11(10):4910–4917.

Robles–Aguilar M, Jaramillo–Jaramillo C, Rojas–de–Astudillo L. Contenido de betalainas y actividad antioxidante en brácteas de Bougainvillea glabra Choisy. Rev. Cubana Farmac. [Internet] 2018 [Consultado 3 Jul 2022]; 51(2):1–7. Disponible en: https://bit.ly/3oLxGH3.

Wu Q, Fu X, Chen Z, Wang H, Wang J, Zhu Z, Zhu G. Composition, color stability and antioxidant properties of betalain–based extracts from bracts of Bougainvillea. Molecules. 2022; 27(16):5120. doi: https://doi.org/kc63

Organización Mundial de la Salud. Directrices de la OMS sobre buenas prácticas agrícolas y de recolección (BPAR) de plantas medicinales. [Internet]. Ginebra: OMS; 2003 [Consultado 7 Mar 2022]; 79 p. Disponible en: https://bit.ly/3NapVnk.

Miranda M. Farmacognosia y productos naturales. 2da. ed. Editorial Félix Varela. 2012; p 127–130.

World Health Organization. Quality control methods for herbal materials. [Internet]. Geneva: WHO Press; 2011 [Consultado 10 Mar 2022]; 187 p. Disponible en: https://bit.ly/43n7wta.

Vinatoru M. An overview of the ultrasonically assisted extraction of bioactive principles from herbs. Ultrason. Sonochem. 2001; 8(3):303–313. doi: https://doi.org/brwxj3

Sreevidya N, Mehrotra S. Spectrophotometric method for estimation of alkaloids precipitable with Dragendorff’s reagent in plant materials. J. AOAC. Intern. 2003; 86(6):1124–1127.

National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. [Internet]. Washington (DC): National Academies Press; 2011 [8th edition; Consultado 7 Feb 2022]; 220 p. Disponible en: https://bit.ly/3MSAQ3M.

Organization for Economic Cooperation and Development (OECD), Test No. 425: Acute Oral Toxicity: Up–and–Down Procedure, OECD Guidelines for the testing of chemicals, Section 4. [Internet]. Paris: OECD Publishing: 2022 [Consultado 17 Jul 2022]; p 4–7. Disponible en: https://doi.org/cmwdqd

Mathiasen JR, Moser VC. The Irwin Test and Functional Observational Battery (FOB) for assessing the effects of compounds on behavior, physiology, and safety pharmacology in rodents. Curr. Protoc. Pharmacol. 2018; 83(1):e43. doi: https://doi.org/gjt3wb

Chakraborty R, De B, Devanna N, Sen S. Antitussive, expectorant activity of Marsilea minuta L., an Indian vegetable. J. Adv. Pharm. Technol. Res. 2013; 4(1):61–4. doi: https://doi.org/f4v3c7

Islam MZ, Hossain MT, Hossen F, Akter MS, Mokammel MA. In–vitro antioxidant and antimicrobial activity of Bougainvillea glabra flower. Res. J. Med. Plant. 2016; 10(3):228–236.

Shalini M, Aminah A, Khalid HM, Vimala S, Katherine S, Khoo MGH. In–vitro antioxidant activities, phytoconstituents and toxicity evaluation of local Bougainvillea glabra bract (Bunga Kertas). Intern. J. Chemtech Res. 2018; 11(9):22–30. doi: https://doi.org/kc64

Teh L, Kue C, Ng C, Lau B. Toxicity effect of Bougainvillea glabra (Paper Flower) water extracts on zebrafish embryo. ITPS. 2019; 2(1):25–28. doi: https://doi.org/kc66

Redpath JB, Pleuvry BJ. Double–blind comparison of the respiratory and sedative effects of codeine phosphate and (+/-)–glaucine phosphate in human volunteers. Br. J. Clin. Pharmacol. 1982; 14(4):555–8. doi: https://doi.org/kc7b

Kamei J. Role of opioidergic and serotonergic mechanisms in cough and antitussives. Pulm. Pharmacol. 1996; 9:349–356.

Jaramillo C, Armijos J, Cedeño R, Campo M, Rojas de AL. Comparación de la relación de fenoles totales, flavonoides y capacidad antioxidante en brácteas de dos variedades de Bougainvillea glabra Choisy. InfoAnalit. 2021; 91:167–179. https://doi.org/kc7c

Ul Haq R, Wahab A, Ayub K, Mehmood K, Sherkheli MA, Khan RA, Raza M. Antitussive efficacy and safety profile of ethyl acetate fraction of Terminalia chebula. ISRN Pharmacol. 2013; 2013:256934. doi: https://doi.org/gb66d5

Published
2023-06-08
How to Cite
1.
Jaramillo-Jaramillo CG, Zambrano- Gonzaga KA, Armijos-Aguilar JC, Cuenca-Buele SA, Tocto-León M, Rojas de Astudillo L. Evaluation of alkaloid contents, acute toxicity and antitussive activity of the bracts of two varieties of Bougainvillea glabra Choisy. Rev. Cient. FCV-LUZ [Internet]. 2023Jun.8 [cited 2024May19];33(2):1-. Available from: https://produccioncientificaluz.org/index.php/cientifica/article/view/40300
Section
Veterinary Medicine